| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |